Miromatrix Medical Inc.
(NASDAQ CM: MIRO)
Rigrodsky Law, P.A. is investigating Miromatrix Medical Inc. (“Miromatrix”) regarding possible breaches of fiduciary duties and other violations of law related to Miromatrix’s agreement to be acquired by United Therapeutics Corporation. Under the terms of the agreement, Miromatrix shareholders will receive $3.25 per share in cash.